Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Negative PR vs positive PR

It's common sense for a publicly traded company to avoid the release of relevant PRs in a timely fashion because they're afraid of a message board?

You must have peculiar definitions of "common" and "sense."

Share
New Message
Please login to post a reply